⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
166,302.99
+0.20%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.12
+0.22%
Gold
$4,143.04
+0.05%
Brent
$109.88
+0.60%
BTC
$81,931.77
+0.11%
ETH
$2,406.64
+0.06%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
166,302.99
+0.20%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.12
+0.22%
Gold
$4,143.04
+0.05%
Brent
$109.88
+0.60%
BTC
$81,931.77
+0.11%
ETH
$2,406.64
+0.06%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› BBIO
B
BridgeBio Pharma Inc
NAS:BBIO
Healthcare
NASDAQ:NBI
NASDAQ:NQUSMG
—
—
At close · Market cap
—
· Next earnings
Wed 28 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
BridgeBio Pharma Inc · News · TradingHolo
BBIO news
Headlines tagged to this company
BE
BridgeBio Dwarfism Data Shows Broad Health Benefits Beyond Height Gain
benzinga · 41 d ago
GL
Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial
globenewswire · 41 d ago
GL
BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers
globenewswire · 41 d ago
GL
BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026
globenewswire · 48 d ago
GL
BBOT to Participate in Upcoming Investor Healthcare Conferences
globenewswire · 48 d ago
GL
BridgeBio to Participate in September Investor Conferences
globenewswire · 49 d ago
GL
BridgeBio Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
globenewswire · 49 d ago
TH
BridgeBio Stock Has Soared 29% in Just 3 Months. Here's Why Wall Street Thinks It Could Go Even Higher.
The Motley Fool · 67 d ago
GL
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
GlobeNewsWire · 67 d ago
GL
BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder
GlobeNewsWire · 67 d ago
ZA
BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge
Zacks Investment Research · 70 d ago
SE
BridgeBio: Attruby Delivers In Q2, Expect Three New Launches In 12 Months
Seeking Alpha · 70 d ago
SE
BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call Transcript
Seeking Alpha · 70 d ago
ZA
BridgeBio Pharma (BBIO) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Research · 70 d ago
MA
BridgeBio Pharma Q2 Earnings Call Highlights
MarketBeat · 70 d ago
GL
BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET
GlobeNewsWire · 78 d ago
← Previous
End of the feed